Surendra Chaurasia, head of the supply management branch of the health service department, said that 664,650 doses of Pfizer vaccine were received this morning under the COVAX facility.
Surendra Chaurasia, head of the supply management branch of the health service department, said that 664,650 doses of Pfizer vaccine were received this morning under the COVAX facility.
GENEVE, September 22: Director-General of the World Health Organization (WHO) Tedros Adhanom Ghebreyesus on Wednesday extended gratitude to India for resuming crucial COVID vaccine shipments to COVAX from October.
Ghebreyesus also said that the move will help WHO to reach its goal of 40 per cent vaccination in all countries by the end of the year. "Thank you Health Minister Mansukh Mandaviya for announcing India will resume crucial COVID-19 vaccine shipments to COVAX in October. This is an important development in support of reaching the 40 per cent vaccination target in all countries by the end of the year. #VaccinEquity," Ghebreyesus said in a tweet.
The remark of WHO's Director-General came after Union Minister of Health and Family Welfare Mansukh Mandaviya announced that in the fourth quarter of 2021, the government of India will resume 'Vaccine Maitri', an initiative to provide COVID vaccines to countries around the world and also fulfil its responsibility under COVAX.
Mandaviya also announced that the Indian government is expecting more than 30 crore doses from vaccine manufacturers in the month of October.
Meanwhile, with the administration of 37,78,296 vaccine doses in the last 24 hours, India's COVID-19 vaccination coverage surpassed the landmark figure of 80 crores (80,85,68,144) as per provisional reports till 7 am on Wednesday. This was achieved through 79,78,302 sessions, the Indian Ministry of Health said.
The government is set to receive 100,000 doses of Pfizer–BioNTech COVID-19 vaccine to be delivered under the COVAX sharing scheme for poorer countries.
KATHMANDU, July 21: People above 18 years of age will also receive Johnson and Johnson vaccine against the coronavirus disease in Kathmandu district from Wednesday.
The Department of Health Services shared that as many 140,000 doses of the single-shot vaccine were handed over to the district.
The vaccine, which is being administered to people between 50 and 54 years of age, people with disabilities, those flying to abroad and refugees, will also be provided to the young people above 18.
The US government donated a total of 1,534,850 doses of the J&J vaccine under the COVAX facility.
KATHMANDU, June 7: The government is preparing to administer the AstraZeneca COVID-19 vaccine as an alternative to the booster dose the Covishield vaccine.
The government ‘s decision comes after the Serum Institute of India, the manufacturing company of Covishield vaccine and the COVAX Facility expressed inability to supply additional quantities of Covishield vaccines to Nepal for the time being.
The Ministry of Health and Population (MOHP) is planning to administer the AstraZeneca vaccine for those waiting for the booster shot of Covishield as both vaccines are similar in nature and composition.
Director of Family Welfare Division, Department of Health Services, Dr Taranath Pokhrel said that AstraZeneca will be provided to those receiving the first jab of Covishield as both vaccines were developed by the same company being based on the same formula and methodology and it would make no difference in giving the AstraZeneca as an alternative to the Covishield.
The vaccination schedule is yet to be fixed. The booster or second dose is to be taken after 12-16 weeks of getting the first shot.
\Around 1.4 million people above 65 years of age were provided the first shot of Covishield from 7th March to 23rd March. They are waiting for the final shot as the Serum Institute of India expressed its inability to supply one million doses of vaccines that Nepal had procured from the company for the time being in view of the increasing infections rate in India.
So far in Nepal, the number of the population receiving the first shot of COVID-19 jab stands at 2.13 million while 691,184 have received the full course. The government is administering the China –manufactured Vero Cell to the people from 60-64 age group from tomorrow, Tuesday.
